In Vitro testing of Bilastine For Transporter Mediated Drug-Drug Interactions

被引：0
|
作者：
Ganza, Alvaro [1 ]
Ortega, Ignacio [1 ]
Gonzalo, Ana [1 ]
Luisa Lucero, Maria [1 ]
Jahic, Mirza [2 ]
Bednarczyk, Dallas [2 ]
Gedey, Szilvia
Nagy, Zoltan [4 ]
Juhasz, Viktoria [4 ]
Ioja, Eniko [3 ]
机构：
[1] Faes Farma, RDi, Vizcaya, Spain
[2] Optivia Biotechnol Inc, Menlo Pk, CA USA
[3] SOLVO Biotechnol, Res & Dev, Szeged, Hungary
[4] SOLVO Biotechnol, R&D, Budaors, Hungary
来源：
DRUG METABOLISM REVIEWS | 2010年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：303 / 303
页数：1
相关论文
共 50 条
  • [31] A Review of CYP-Mediated Drug Interactions: Mechanisms and In Vitro Drug-Drug Interaction Assessment
    Lee, Jonghwa
    Beers, Jessica L.
    Geffert, Raeanne M.
    Jackson, Klarissa D.
    BIOMOLECULES, 2024, 14 (01)
  • [32] ITC Commentary on the Prediction of Digoxin Clinical Drug-Drug Interactions from In Vitro Transporter Assays
    Lee, C. A.
    Kalvass, J. C.
    Galetin, A.
    Zamek-Gliszczynski, M. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (03) : 298 - 301
  • [33] STATISTICAL ANALYSIS TO COMPARE VARIOUS IN VITRO CRITERIA FOR PREDICTING P-GLYCOPROTEIN TRANSPORTER MEDIATED DRUG-DRUG INTERACTIONS IN VIVO
    Arya, V.
    Zhou, T.
    Yang, X.
    Vaidyanathan, J.
    Zhang, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S21 - S21
  • [34] In vitro assessment of P-gp and BCRP transporter-mediated drug-drug interactions of riociguat with direct oral anticoagulants
    Jacqueroux, Elodie
    Mercier, Clement
    Margelidon-Cozzolino, Victor
    Hodin, Sophie
    Bertoletti, Laurent
    Delavenne, Xavier
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2020, 34 (01) : 109 - 119
  • [35] Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions
    Britz, Hannah
    Hanke, Nina
    Taub, Mitchell E.
    Wang, Ting
    Prasad, Bhagwat
    Fernandez, Eric
    Stopfer, Peter
    Nock, Valerie
    Lehr, Thorsten
    PHARMACEUTICAL RESEARCH, 2020, 37 (12)
  • [36] IN VITRO-IN VIVO CORRELATION FOR TRANSPORTER-MEDIATED DRUG-DRUG INTERACTIONS WITH ROSUVASTATIN USING STATIC AND PBPK MODELS.
    Sane, R.
    Cheung, K.
    Kovacs, P.
    Farasyn, T.
    Plise, E.
    Bui, A.
    Musib, L.
    Kis, E.
    Li, R.
    Gaborik, Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S60 - S61
  • [37] Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions
    Nina Hanke
    José David Gómez-Mantilla
    Naoki Ishiguro
    Peter Stopfer
    Valerie Nock
    Pharmaceutical Research, 2021, 38 : 1645 - 1661
  • [38] Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions
    Varma, Manthena V. S.
    Lai, Yurong
    Feng, Bo
    Litchfield, John
    Goosen, Theunis C.
    Bergman, Arthur
    PHARMACEUTICAL RESEARCH, 2012, 29 (10) : 2860 - 2873
  • [39] Mechanistic Modeling to Predict the Transporter- and Enzyme-Mediated Drug-Drug Interactions of Repaglinide
    Varma, Manthena V. S.
    Lai, Yurong
    Kimoto, Emi
    Goosen, Theunis C.
    El-Kattan, Ayman F.
    Kumar, Vikas
    PHARMACEUTICAL RESEARCH, 2013, 30 (04) : 1188 - 1199
  • [40] Metformin and cimetidine: Physiologically based pharmacokinetic modelling to investigate transporter mediated drug-drug interactions
    Burt, H. J.
    Neuhoff, S.
    Almond, L.
    Gaohua, L.
    Harwood, M. D.
    Jamei, M.
    Rostami-Hodjegan, A.
    Tucker, G. T.
    Rowland-Yeo, K.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 88 : 70 - 82
12345